Abstract
Backgrounds The emerging virus, COVID-19, has caused a massive out-break worldwide. Based on the publicly available contact-tracing data, we identified 337 transmission chains from 10 provinces in China and estimated the serial interval (SI) and generation interval (GI) of COVID-19 in China.
Methods Inspired by possibly different values of the time-varying reproduction number for the imported cases and the local cases in China, we divided all transmission events into three subsets: imported (the zeroth generation) infecting 1st-generation locals, 1st-generation locals infecting 2nd-generation locals, and others transmissions among 2+ generations. The corresponding SI (GI) is respec-tively denoted as , and . A Bayesian approach with doubly interval-censored likelihood is employed to fit the lognormal, gamma, and Weibull distribution function of the SI and GI using the identified 337 transmission chains.
Findings It is found that the estimated , and , thus overall both SI and GI decrease when generation increases.
- COVID-19
- serial interval
- generation interval
- statistical analysis
- contact tracing
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
This work is partly supported by the National Key Research and Development Plan (2017YFC1502901) and the National Natural Science Foundation of China (grant no. 71974017).
Author Declarations
All relevant ethical guidelines have been followed; any necessary IRB and/or ethics committee approvals have been obtained and details of the IRB/oversight body are included in the manuscript.
Yes
All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.
Yes
Data Availability
Data used for this study are all from publicly available sources. The data files are available upon request to the authors.